A revisit of the mode of interaction of small transcription inhibitors with genomic DNA

Journal of Biosciences

Volumn 37, Issue 3, 2012, Pages 475-481

  Dasgupta, Dipak ^a   Majumder, Parijat ^a   Banerjee, Amrita ^a  

^a SAHA INSTITUTE OF NUCLEAR PHYSICS   (India)

Author keywords

Dual mode of binding; Groove binders; Intercalators; Single mode of binding; Transcription inhibitors

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; 4',6 DIAMIDINO 2 PHENYLINDOLE; CHROMOMYCIN; CONGOCIDINE; DACTINOMYCIN; DAUNORUBICIN; DIMINAZENE ACETURATE; DISTAMYCIN A; DOUBLE STRANDED DNA; DOXORUBICIN; ETHIDIUM BROMIDE; GENOMIC DNA; HISTONE; HOE 33342; INTERCALATING AGENT; MITHRAMYCIN; SANGUINARINE; TRANSCRIPTION INHIBITOR; UNCLASSIFIED DRUG;

CHEMICAL BINDING; DNA; GENOME; GENOMICS;

CELL NUCLEUS; CHROMATIN; CONFERENCE PAPER; DNA STRUCTURE; DRUG BINDING; DRUG DNA BINDING; DRUG MECHANISM; DRUG TARGETING; MOLECULAR INTERACTION; NONHUMAN;

ANTINEOPLASTIC AGENTS; CHROMATIN; DNA; GENOME; HUMANS; HYDROGEN BONDING; INTERCALATING AGENTS; NEOPLASMS; NUCLEIC ACID CONFORMATION; NUCLEIC ACID SYNTHESIS INHIBITORS; TRANSCRIPTION, GENETIC;

EID: 84864365456     PISSN: 02505991     EISSN: 09737138     Source Type: Journal    
DOI: 10.1007/s12038-012-9211-9     Document Type: Conference Paper

References (38)

1. Adhya D and Basu A 2010 Epigenetic modulation of host: new insights into immune evasion by viruses. J. Biosci. 35 647-663
2. Ahn SY, Cho CH, Park KG, Lee HJ, Lee S, Park SK, Lee IK and Koh GY 2004 Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression. Am. J. Pathol. 164 1663-72
3. Breslauer KJ, Remeta DP, Chou WY, Ferrante R, Curry J, Zaunczkowski D, Snyder JG and Marky LA 1987 Enthalpy-entropy compensations in drug-DNA binding studies. Proc. Natl. Acad. Sci. USA 84 8922-8926
4. Brown PM and Fox KR 1996 Minor groove binding ligands alter the rotational positioning of DNA fragments on nucleosome core particles. J. Mol. Biol. 262 671-685
5. Chaires JB 1997 Energetics of drug-DNA interactions. Biopolymers 44 201-215
6. Devi PG, Chakraborty PK and Dasgupta D 2009 Inhibition of a Zn (II)-containing enzyme, alcohol dehydrogenase, by anticancer antibiotics, mithramycin and chromomycin A3. J. Biol. Inorg. Chem. 14 347-359
7. Ferrante RJ, Ryu H, Kubilus JK, D'mello S, Sugars KL, Lee J, Lu P, Smith K, et al. 2004 Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease. J. Neurosci. 24 10335-10342
8. Ghosh S, Majumder P, Pradhan SK and Dasgupta D 2010 Mechanism of interaction of small transcription inhibitors with DNA in the context of chromatin and telomere. Biochim. Biophys. Acta 1799 795-809
9. Hajihassan Z and Rabbani-Chadegani A 2011 Interaction of mitoxantrone, as an anticancer drug, with chromatin proteins, core histones and H1, in solution. Int. J. Biol. Macromol. 48 87-92
10. Hajihassan Z and Rabbani-Chadegani A 2009 Studies on the binding affinity of anticancer drug mitoxantrone to chromatin, DNA and histone proteins. J. Biomed. Sci. 16 31
11. Haq I 2002 Thermodynamics of drug-DNA interactions. Arch. Biochem. Biophys. 403 1-15
12. Hurley LH 2002 DNA and its associated processes as targets for cancer therapy. Nat. Rev. Cancer 2 188-200
13. Kopka ML, Yoon C, Goodsell D, Pjura P and Dickerson RE 1985 The molecular origin of DNA-drug specificity in netropsin and distamycin. Proc. Natl. Acad. Sci. USA 82 1376-1380
14. Kornberg RD 1977 Structure of chromatin. Annu. Rev. Biochem. 46 931-954
15. Lahiri S, Takao T, Devi PG, Ghosh S, Ghosh A, Dasgupta A and Dasgupta D 2011 Association of aureolic acid antibiotic, chromomycin A3 with Cu(2+) and its negative effect upon DNA binding property of the antibiotic. Biometals 25 435-450
16. Lohse J, Dahl O and Nielsen PE 1999 Double duplex invasion by peptide nucleic acid: a general principle for sequence-specific targeting of double-stranded DNA. Proc. Natl. Acad. Sci. USA 96 11804-11808
17. Low CM, Drew HR and Waring MJ 1986 Echinomycin and distamycin induce rotation of nucleosome core DNA. Nucleic Acids Res. 14 6785-6801
18. Luger K, Mader AW, Richmond RK, Sargent DF and Richmond TJ 1997 Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389 251-260
19. Majumder P and Dasgupta D 2011 Effect of DNA Groove Binder Distamycin A upon chromatin structure. PLoS One 6 e26486
20. Majumder P, Pradhan SK, Devi PG, Pal S and Dasgupta D 2007 Chromatin as a target for the DNA-binding anticancer drugs. Subcell Biochem. 41 145-189
21. Mcghee JD and Felsenfeld G 1980 Nucleosome structure. Annu. Rev. Biochem. 49 1115-1156
22. Mcmurray CT and Van Holde KE 1986 Binding of ethidium bromide causes dissociation of the nucleosome core particle. Proc. Natl. Acad. Sci. USA 83 8472-8476
23. Mir MA, Das S and Dasgupta D 2004 N-terminal tail domains of core histones in nucleosome block the access of anticancer drugs, mithramycin and daunomycin, to the nucleosomal DNA. Biophys. Chem. 109 121-135
24. Mir MA and Dasgupta D 2003 Association of anticancer drug mithramycin with H1-depleted chromatin: a comparison with native chromatin. J. Inorg. Biochem. 94 72-77
25. Mir MA, Majee S, Das S and Dasgupta D 2003 Association of chromatin with anticancer antibiotics, mithramycin and chromomycin A3. Bioorg. Med. Chem. 11 2791-2801
26. Nelson SM, Ferguson LR and Denny WA 2007 Non-covalent ligand/DNA interactions: minor groove binding agents. Mutat. Res. 623 24-40
27. Nielsen PE 1999 Peptide nucleic acids as therapeutic agents. Curr. Opin. Struct. Biol. 9 353-357
28. Palchaudhuri R and Hergenrother PJ 2007 DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action. Curr. Opin. Biotechnol. 18 497-503
29. Panigrahi SK and Desiraju GR 2007 Strong and weak hydrogen bonds in drug-DNA complexes: a statistical analysis. J. Biosci. 32 677-691
30. Rabbani A, Finn RM, Thambirajah AA and Ausio J 2004 Binding of antitumor antibiotic daunomycin to histones in chromatin and in solution. Biochemistry 43 16497-16504
31. Rabbani A, Iskandar M and Ausio J 1999 Daunomycin-induced unfolding and aggregation of chromatin. J. Biol. Chem. 274 18401-18406
32. Rentzeperis D, Marky LA, Dwyer TJ, Geierstanger BH, Pelton JG and Wemmer DE 1995 Interaction of minor groove ligands to an AAATT/AATTT site: correlation of thermodynamic characterization and solution structure. Biochemistry 34 2937-2945
33. Saenger W 1984 Principles of nucleic acid structure (New York: Springer-Verlag)
34. Selvi BR, Pradhan SK, Shandilya J, Das C, Sailaja BS, Shankar GN, Gadad SS, Reddy A, Dasgupta D and Kundu TK 2009 Sanguinarine interacts with chromatin, modulates epigenetic modifications, and transcription in the context of chromatin. Chem. Biol. 16 203-216
35. Singh B and Gupta RS 1983 Mutagenic responses of thirteen anticancer drugs on mutation induction at multiple genetic loci and on sister chromatid exchanges in Chinese hamster ovary cells. Cancer Res. 43 577-584
36. Spolar RS and Record MT Jr 1994 Coupling of local folding to sitespecific binding of proteins to DNA. Science 263 777-784
37. Taquet A, Labarbe R and Houssier C 1998 Calorimetric investigation of ethidium and netropsin binding to chicken erythrocyte chromatin. Biochemistry 37 9119-9126
38. Thuong NT and Helene C 1993 Sequence specific recognition and modification of double helical DNA by oligonucleotides. Angewandte Chemie Int. Ed. English 32 666-690